DRUG DEVELOPMENT: The breakthrough trial of aducanumab for Alzheimer’s recently made headline news. The FDA’s Fast Track program speeds up the development of new treatments
MAJOR ADVANCE – VIDEO & ARTICLE: A new experimental drug called “aducanumab” significantly slowed memory, thinking and cognitive decline in Alzheimer’s. It works by almost
MEMORY: In Alzheimer’s, it’s hard to find a way to boost memory. New research has uncovered a big reason why. It seems that over-boosting memory
DRUG TRIAL VIDEO & ARTICLE: See how the investigational new drug, T3D-959, elicited rapid improvement in cognitive tests in 53% of subjects with Alzheimer’s. Look
VIDEO + ARTICLE: New 3D imaging technology is uncovering Alzheimer’s hard-to-solve secrets. See how sheets of light are shedding light on curing Alzheimer’s.
VIDEO – TODAY SHOW: The 3-year A4-Trial is using solanezumab to slow memory loss caused by Alzheimer’s. See how this government-sponsored nationwide trial is making
HEALTH RESEARCH VIDEO + ARTICLE: Can a retinal-scan at an early age predict future development of Alzheimer’s? Can you use that prediction to lessen your
At the White House, in Congress and even on the presidential campaign – three places where virtually nothing is agreed upon – there is a
VIDEO + ARTICLE: Aducanumab for Alzheimer’s is showing encouraging results as Phase 3 trials roll out. See how this new immunotherapy is treating Alzheimer’s at
VIDEO + ARTICLE: In an effort to educate potential volunteers to try RVT-101 in a clinical trial, the MINDSET STUDY is trying something new. Doctors
The new Alzheimer’s antibodies, Leqembi and Kisunla, work better on some people than others. A cutting-edge technique called spatial transcriptomics may help figure out how to make them work better for everybody.
VIDEO: This is not a story about dementia. This is a story about Liz.
COMMUNICATIONS VIDEO + TRANSCRIPT: In Alzheimer’s, talking to a loved one can be very frustrating. Here are 3 tips that can help.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
